@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix go: . @prefix Protein: . @prefix pfm: . @prefix geneProductOf: . @prefix hasAgent: . @prefix mgi: . @prefix proteinModification: . @prefix psimod: . @prefix species: . @prefix occursIn: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 hasAgent: sub:_2; a go:0016301 . sub:_2 geneProductOf: pfm:Akt%20Family; a Protein: . sub:_3 belv:variantOf mgi:1914855; a proteinModification:, psimod:00696 . sub:_4 occursIn: species:10090; rdf:object sub:_3; rdf:predicate belv:directlyIncreases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "kin(p(PFM:\"Akt Family\")) => p(MGI:Akt1s1,pmod(P,T,246))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_6; pav:version "1.4" . sub:_5 prov:value "PRAS40 was phosphorylated in vitro by purified Akt on the same site that was phosphorylated in insulin-treated cells. (From Results section) -- To determine whether the predicted Akt consensus phosphorylation site (Thr-246) was in fact the site recognized by the anti-pAkt substrate antibody, a mutant form of the HA-tagged PRAS40 (T246A) was expressed in which this site was changed to Ala. The anti-pAkt substrate did not recognize the mutant PRAS40, even when the constitutively active Akt was co-expressed with this protein (Fig. 5). --"; prov:wasQuotedFrom pubmed:12524439 . sub:_6 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:12524439; prov:wasDerivedFrom beldoc:, sub:_5 . } sub:pubinfo { this: dct:created "2014-07-03T14:30:09.280+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }